These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35652904)

  • 1. Structure-guided pharmacophore based virtual screening, docking, and molecular dynamics to discover repurposed drugs as novel inhibitors against endoribonuclease Nsp15 of SARS-CoV-2.
    Jha P; Saluja D; Chopra M
    J Biomol Struct Dyn; 2023 Jul; 41(11):5096-5106. PubMed ID: 35652904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacoinformatics approach based identification of potential Nsp15 endoribonuclease modulators for SARS-CoV-2 inhibition.
    Savale RU; Bhowmick S; Osman SM; Alasmary FA; Almutairi TM; Abdullah DS; Patil PC; Islam MA
    Arch Biochem Biophys; 2021 Mar; 700():108771. PubMed ID: 33485847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of potential inhibitors against SARS-CoV-2 endoribonuclease: RNA immunity sensing.
    Al-Rashedi NAM; Munahi MG; Ah ALObaidi L
    J Biomol Struct Dyn; 2022 Jul; 40(11):4879-4892. PubMed ID: 33357040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of potential target endoribonuclease NSP15 inhibitors of SARS-COV-2 from natural products through high-throughput virtual screening and molecular dynamics simulation.
    Hu LC; Ding CH; Li HY; Li ZZ; Chen Y; Li LP; Li WZ; Liu WS
    J Food Biochem; 2022 May; 46(5):e14085. PubMed ID: 35128681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug designing against NSP15 of SARS-COV2 via high throughput computational screening and structural dynamics approach.
    Batool A; Bibi N; Amin F; Kamal MA
    Eur J Pharmacol; 2021 Feb; 892():173779. PubMed ID: 33275961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reporting dinaciclib and theodrenaline as a multitargeted inhibitor against SARS-CoV-2: an
    Ahmad S; Pasha Km M; Raza K; Rafeeq MM; Habib AH; Eswaran M; Yadav MK
    J Biomol Struct Dyn; 2023 Jun; 41(9):4013-4023. PubMed ID: 35451934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of RdRp inhibitors against SARS-CoV-2 through E-pharmacophore-based virtual screening, molecular docking and MD simulations approaches.
    Rehman HM; Sajjad M; Ali MA; Gul R; Naveed M; Aslam MS; Shinwari K; Bhinder MA; Ghani MU; Saleem M; Rather MA; Ahmad I; Amin A
    Int J Biol Macromol; 2023 May; 237():124169. PubMed ID: 36990409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virtual screening and structure-based 3D pharmacophore approach to identify small-molecule inhibitors of SARS-CoV-2 M
    Elseginy SA
    J Biomol Struct Dyn; 2022; 40(24):13658-13674. PubMed ID: 34676801
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Maurya AK; Mishra N
    J Biomol Struct Dyn; 2021 Nov; 39(18):7306-7321. PubMed ID: 32835632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying non-nucleoside inhibitors of RNA-dependent RNA-polymerase of SARS-CoV-2 through per-residue energy decomposition-based pharmacophore modeling, molecular docking, and molecular dynamics simulation.
    Aziz S; Waqas M; Mohanta TK; Halim SA; Iqbal A; Ali A; Khalid A; Abdalla AN; Khan A; Al-Harrasi A
    J Infect Public Health; 2023 Apr; 16(4):501-519. PubMed ID: 36801630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of promising antiviral drug candidates against non-structural protein 15 (NSP15) from SARS-CoV-2: an
    Khan RJ; Jha RK; Singh E; Jain M; Amera GM; Singh RP; Muthukumaran J; Singh AK
    J Biomol Struct Dyn; 2022 Jan; 40(1):438-448. PubMed ID: 32885740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational repurposing approach for targeting the critical spike mutations in B.1.617.2 (delta), AY.1 (delta plus) and C.37 (lambda) SARS-CoV-2 variants using exhaustive structure-based virtual screening, molecular dynamic simulations and MM-PBSA methods.
    Ebrahimi M; Karami L; Alijanianzadeh M
    Comput Biol Med; 2022 Aug; 147():105709. PubMed ID: 35728285
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Sharma A; Goyal S; Yadav AK; Kumar P; Gupta L
    J Biomol Struct Dyn; 2022 Jan; 40(1):86-100. PubMed ID: 32896226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of phytochemicals as potential therapeutic agents that binds to Nsp15 protein target of coronavirus (SARS-CoV-2) that are capable of inhibiting virus replication.
    Kumar S; Kashyap P; Chowdhury S; Kumar S; Panwar A; Kumar A
    Phytomedicine; 2021 May; 85():153317. PubMed ID: 32943302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular dynamics simulation, 3D-pharmacophore and scaffold hopping analysis in the design of multi-target drugs to inhibit potential targets of COVID-19.
    Fayyazi N; Mostashari-Rad T; Ghasemi JB; Ardakani MM; Kobarfard F
    J Biomol Struct Dyn; 2022; 40(22):11787-11808. PubMed ID: 34405765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational investigation of potent inhibitors against SARS-CoV-2 2'-O-methyltransferase (nsp16): Structure-based pharmacophore modeling, molecular docking, molecular dynamics simulations and binding free energy calculations.
    Shi L; Wen Z; Song Y; Wang J; Yu D
    J Mol Graph Model; 2022 Dec; 117():108306. PubMed ID: 36063745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the inhibitory potential of bioactive compounds against SARS-CoV-2 by in silico approach.
    Rani JMS; Akkarshana P; Neelaveni V; Mohan S; Rekha PD; Rao RM; Muthulakshmi L
    J Mol Model; 2024 Feb; 30(3):60. PubMed ID: 38321299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of nonstructural protein 15 of SARS-CoV-2 by golden spice: A computational insight.
    Singh R; Bhardwaj VK; Purohit R
    Cell Biochem Funct; 2022 Dec; 40(8):926-934. PubMed ID: 36203381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico identification of novel SARS-COV-2 2'-O-methyltransferase (nsp16) inhibitors: structure-based virtual screening, molecular dynamics simulation and MM-PBSA approaches.
    El Hassab MA; Ibrahim TM; Al-Rashood ST; Alharbi A; Eskandrani RO; Eldehna WM
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):727-736. PubMed ID: 33685335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tackling COVID-19: identification of potential main protease inhibitors via structural analysis, virtual screening, molecular docking and MM-PBSA calculations.
    Al-Shar'i NA
    J Biomol Struct Dyn; 2021 Oct; 39(17):6689-6704. PubMed ID: 32734828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.